Table 2.
Patients' basic characteristics
| Population (N = 126) | Group A (n = 43) | Group B (n = 52) | |
|---|---|---|---|
| Age (y) | 64.9 (10.5) | 64.4 (8.3) | 66.8 (8.2) |
| BMI (kgm2) | 27.4 (3.6) | 27.6 (3.1) | 27.3 (3.8) |
| Total testosterone (nmol/dL) | 14.0 (4.4) | 13.1 (4.1) | 14.4 (4.9) |
| Smoking status | 22 (17.5%) | 12 (27.9%) | 6 (10.9%) |
| Myocardial infarction | 15 (11.9%) | 6 (13.9%) | 5 (11.7%) |
| Hypercholesterolemia | 93/54∗ (73.8%) | 33/20∗ (76.7%) | 35/22∗ (67.3%) |
| Peripheral artery disease | 11 (8.7%) | 2 (4.6%) | 8 (15%) |
| Hypertension | 54 (42.8%) | 15 (34.9%) | 22 (42.3%) |
| Diabetes | 15 (11.9%) | 7 (16.3%) | 3 (5.8%) |
| Treatment with PDE5i | — | 24 (56%) | 30 (58.0%) |
BMI = body mass index; PDE5i = phosphodiesterase type 5 inhibitor.
∗
Diagnosed during screening.